Farastuk Bozorgmehr

机构：Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, German Center for Lung Research · ORCID：0000-0001-8058-8884

发表论文 129 篇 · 总被引 2141 次 · h-index 23

代表论文

• Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial (2025 · Journal of Thoracic Oncology · 被引 38)
• MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial (2026 · Nature Medicine · 被引 4)
• Dermatologic prophylaxis and impact on patient-reported outcomes in first-line EGFR -mutant advanced NSCLC treated with amivantamab plus lazertinib: Results from the phase 2 COCOON trial. (2025 · Journal of Clinical Oncology · 被引 4)
• Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial (2025 · Neuro-Oncology · 被引 3)
• Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415) (2025 · Clinical & Experimental Metastasis · 被引 3)
• Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer (2026 · JAMA Oncology · 被引 1)